Fig. 2

Predictors for relapse with blinatumomab and ponatinib in newly diagnosed Ph + ALL. (A) Forest plot for univariate analysis and (B) Forest plot for multivariate analysis
Predictors for relapse with blinatumomab and ponatinib in newly diagnosed Ph + ALL. (A) Forest plot for univariate analysis and (B) Forest plot for multivariate analysis